Related Experiment Video
Updated: Jan 13, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.6K
Population-based cohort validation and replication reveals limited generalizability of cluster-based MASLD subtypes
Diabetes, Obesity & Metabolism
|January 7, 2026
Summary
A new study on metabolic dysfunction-associated steatotic liver disease (MASLD) found that while a prior subtyping model had limited generalizability, cardiometabolic and liver-specific patterns consistently emerged for risk stratification.
Area of Science:
- Cardiology
- Hepatology
- Epidemiology
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) presents significant heterogeneity, complicating risk stratification.
- Previous clustering models identified liver-specific and cardiometabolic subtypes but lacked validation in broader populations.
Purpose of the Study:
- To validate and replicate a prior clustering model for MASLD subtypes.
- To assess the prognostic relevance of these subtypes for mortality risks.
Main Methods:
- Utilized data from 3300 MASLD participants in the National Health and Nutrition Examination Survey (NHANES III).
- Employed Partitioning Around Medoids for cluster derivation and Cox proportional hazards models for mortality risk analysis.
- Validated and replicated subtype assignments to assess generalizability.
Main Results:
- Cluster assignments showed limited reproducibility between validation and replication, but overall patterns persisted.
- Identified broad cardiometabolic and liver-specific subtypes.
- The cardiometabolic cluster was associated with consistently higher mortality risks, while the liver-specific cluster showed no significant associations.
Conclusions:
- The MASLD subtyping model demonstrated limited generalizability.
- Consistent identification of cardiometabolic and liver-specific patterns suggests potential utility for risk stratification, requiring further validation.
